For almost a century, the Warburg effect has shaped how we talk about cancer metabolism. But the word “prefer” can hide a more basic question: which fuels and pathways are actually available to a cell, and which are required for its survival?
Hypoxia is not an on–off switch. Between a well-oxygenated region and a severely oxygen-starved region, there may be a metabolic window in which oxygen remains available but glucose-derived pyruvate enters the TCA cycle less readily.
Can tumor cells escape glucose restriction by switching to ketones? In severely hypoxic regions, the central obstacle is oxygen: ketones provide ATP through mitochondrial oxidation and cannot replace glucose as a fuel for anaerobic glycolysis.
Could glutamine become an important ATP fuel at oxygen levels where pyruvate oxidation is already suppressed, but mitochondrial respiration has not yet stopped?
Why do many cancer cells rely so strongly on glycolysis? Thomas Seyfried argues that mitochondrial dysfunction is central to cancer metabolism. We agree that glucose dependence is a potential metabolic vulnerability. We differ on its underlying cause: I believe oxygen, glucose and lactate delivery deserve at least as much attention as the mitochondria themselves.
Glucose and oxygen dominate most discussions of tumor metabolism, but glutamine deserves special attention. Its role changes with the oxygen available to the cell.
Could 96 grams of carbohydrates before cancer surgery affect the tumour and survival? A Norwegian study raises questions about insulin, tumour metabolism and preparation for surgery.
What do animal experiments and clinical studies show about ketogenic diets in cancer? Possible mechanisms, promising findings and important limitations.